Project Eleven | $20,000,000 | (Jan 16, 2026)
CYB3R OPERATIONS | $5,400,000 | (Jan 16, 2026)
Quadric | $30,000,000 | (Jan 16, 2026)
Vista AI
United States
- Palo Alto, California
- 16/01/2026
- Series B
- $29,500,000
Vista AI develops intelligent software to streamline MRI exams. Its FDA-cleared product, Vista AI Scan, automates MRI scanning, enabling all technologists to perform accurate, high-quality scans within a consistent and rapid timeframe. While initially focused on cardiac MRI (CMR), Vista AI will expand the technology to the brain, prostate, spine and other anatomical areas to deliver a full suite of AI-driven MRI capabilities.
- Industry Medical Device
- Website https://vista.ai/
- LinkedIn https://www.linkedin.com/company/vistaai/
Related People
Daniel HawkinsFounder
United States -
Palo Alto, California
CEO of Vista.ai. Vista software enables completion of high-quality MRI scans faster and more consistently than ever before.
Prior to joining Vista, Daniel was the founder and CEO of Avail Medsystems and previously held roles in both large and emerging companies including Advanced Cardiovascular Systems, Inc. (NYSE: ABT), Endologix (NASDAQ: ELGX), Restore Medical (NYSE: MDT - acq.), EnteroMedics (NASDAQ: ETRM), and Intuitive Surgical (NASDAQ: ISRG) where he joined as the 6th employee and drove initial market creation for the DaVinci surgical robot. Daniel is a co-founder of Calibra Medical (CeQur - acq.), and founder of Shockwave Medical, Inc. (NASDAQ: SWAV), where he invented Intravascular Lithotripsy (IVL) and served as CEO. A graduate of the Stanford Graduate School of Business, he is a named inventor on over 160 patents and applications and three times named one of the "100 most Intriguing Entrepreneurs" by Goldman Sachs.
RouteSense | $2,000,000 | (Jan 16, 2026)
depthfirst | $40,000,000 | (Jan 16, 2026)
Slips | $3,500,000 | (Jan 16, 2026)
VoiceRun | $5,500,000 | (Jan 16, 2026)
Emversity | $30,000,000 | (Jan 16, 2026)
Ammobia | $7,500,000 | (Jan 16, 2026)